Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
72.45
+1.05 (1.47%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Soleno Therapeutics stock have an average target of 95.75, with a low estimate of 73 and a high estimate of 123. The average target predicts an increase of 32.16% from the current stock price of 72.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 2 | 2 | 2 | 5 | 5 |
Buy | 4 | 4 | 4 | 4 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 6 | 6 | 6 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +38.03% | Apr 15, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $100 | Strong Buy | Maintains | $70 → $100 | +38.03% | Mar 31, 2025 |
Stifel | Stifel | Strong Buy Maintains $74 → $108 | Strong Buy | Maintains | $74 → $108 | +49.07% | Mar 28, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $70 → $81 | Strong Buy | Maintains | $70 → $81 | +11.80% | Mar 28, 2025 |
Laidlaw & Co. | Laidlaw & Co. | Strong Buy Maintains $75 → $105 | Strong Buy | Maintains | $75 → $105 | +44.93% | Mar 27, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.97
from -4.38
EPS Next Year
0.28
from -2.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 77.2M | 394.8M | 757.1M |
Avg | 36.7M | 234.4M | 453.5M |
Low | 6.8M | 34.3M | 61.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 975.5% | 223.0% |
Avg | - | 538.4% | 93.5% |
Low | - | -6.6% | -73.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.38 | 2.23 | 7.99 |
Avg | -2.97 | 0.28 | 3.90 |
Low | -5.42 | -2.79 | -1.39 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | 2,712.2% |
Avg | - | - | 1,273.4% |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.